| Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Nature 602 (7898), 654-656, 2022 | 1031 | 2022 |
| Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... Nature 593 (7857), 142-146, 2021 | 672 | 2021 |
| T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 495 | 2022 |
| SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... MedRxiv, 2021 | 367 | 2021 |
| SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape S Cele, F Karim, G Lustig, JE San, T Hermanus, H Tegally, J Snyman, ... Cell host & microbe 30 (2), 154-162. e5, 2022 | 175 | 2022 |
| Omicron BA. 4/BA. 5 escape neutralizing immunity elicited by BA. 1 infection K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ... Nature communications 13 (1), 4686, 2022 | 148 | 2022 |
| Escape of SARS-CoV-2 501Y S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... V2 variants from neutralization by convalescent plasma. medRxiv 2026 (10 …, 2021 | 129 | 2021 |
| Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection F Karim, MYS Moosa, BI Gosnell, S Cele, J Giandhari, S Pillay, H Tegally, ... MedRxiv, 2021.06. 03.21258228, 2021 | 100 | 2021 |
| Omicron sub-lineages BA. 4/BA. 5 escape BA. 1 infection elicited neutralizing immunity K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ... MedRxiv, 2022.04. 29.22274477, 2022 | 81 | 2022 |
| Omicron infection enhances Delta antibody immunity in vaccinated persons K Khan, F Karim, S Cele, K Reedoy, JE San, G Lustig, H Tegally, ... Nature 607 (7918), 356-359, 2022 | 72 | 2022 |
| SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... MedRxiv, 2021.12. 26.21268380, 2021 | 60 | 2021 |
| A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy AJ Greaney, TN Starr, RT Eguia, AN Loes, K Khan, F Karim, S Cele, ... PLoS pathogens 18 (2), e1010248, 2022 | 56 | 2022 |
| Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant K Khan, F Karim, S Cele, JE San, G Lustig, H Tegally, Y Rosenberg, ... Medrxiv, 2022 | 54 | 2022 |
| Network for Genomic Surveillance in South Africa; COMMIT-KZN Team, Lessells RJ, de Oliveira T, Sigal A. Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... Nature 593 (7857), 142-146, 2021 | 47 | 2021 |
| HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave F Karim, I Gazy, S Cele, Y Zungu, R Krause, M Bernstein, K Khan, ... Elife 10, e67397, 2021 | 46 | 2021 |
| SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. 2021: 2021.12. 08.21267417 S Cele, L Jackson, K Khan, D Khoury, T Moyo-Gwete, H Tegally DOI 10 (2021.12), 08.21267417, 2021 | 41 | 2021 |
| The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection C Scheepers, J Everatt, DG Amoako, A Mnguni, A Ismail, B Mahlangu, ... Medrxiv, 2021 | 40 | 2021 |
| NGS-SA; COMMIT-KZN Team S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization …, 2022 | 37 | 2022 |
| SARS-CoV-2 Omicron spike mediated immune escape and tropism shift B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ... BioRxiv, 2021.12. 17.473248, 2021 | 35 | 2021 |
| Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26. CoV2. S vaccination in people living with human immunodeficiency virus (HIV) K Khan, G Lustig, M Bernstein, D Archary, S Cele, F Karim, M Smith, ... Clinical Infectious Diseases 75 (1), e857-e864, 2022 | 33 | 2022 |
